[Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
D000293:Adolescent; D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use*; D000990:Antithrombin III / Q000032:analysis; D001772:Blood Cell Count; D001777:Blood Coagulation; D001778:Blood Coagulation Disorders / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis*; D001780:Blood Coagulation Tests; D001792:Blood Platelets; D005260:Female; D006349:Heart Valve Diseases / Q000188:drug therapy; D006467:Hemophilia A / Q000097:blood; D006493:Heparin / Q000032:analysis*; D006494:Heparin Antagonists / Q000032:analysis*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013917:Thrombin; D013927:Thrombosis / Q000188:drug therapy
D000925:Anticoagulants; D001779:Blood Coagulation Factors; D006494:Heparin Antagonists; D000990:Antithrombin III; D006493:Heparin; D013917:Thrombin